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ABSTRACT
Background Poor prognosis after intracerebral
haemorrhage (ICH) is related to haemorrhage
characteristics. Along with developing therapeutic
interventions, we sought to understand the performance
of haemorrhage descriptors in large clinical trials.
Methods Clinical and neuroimaging data were
obtained for 548 participants with ICH from the Efﬁcacy
of Nitric Oxide in Stroke (ENOS) trial. Independent
observers performed visual categorisation of the largest
diameter, measured volume using ABC/2, modiﬁed
ABC/2, semiautomated segmentation (SAS), fully
automatic measurement methods; shape, density and
intraventricular haemorrhage were also assessed.
Intraobserver and interobserver reliability were
determined for these measures.
Results ICH volume was signiﬁcantly different among
standard ABC/2, modiﬁed ABC/2 and SAS: (mean) 12.8
(SD 16.3), 8.9 (9.2), 12.8 (13.1) cm3, respectively
(p<0.0001). There was excellent agreement for
haemorrhage volume (n=193): ABC/2 intraobserver
intraclass correlation coefﬁcient (ICC) 0.96–0.97,
interobserver ICC 0.88; modiﬁed ABC/2 intraobserver
ICC 0.95–0.97, interobserver ICC 0.91; SAS
intraobserver ICC 0.95–0.99, interobserver ICC 0.93;
largest diameter: (visual) interadjudicator ICC 0.82,
(visual vs measured) adjudicator vs observer ICC 0.71;
shape intraobserver ICC 0.88 interobserver ICC 0.75;
density intraobserver ICC 0.86, interobserver ICC 0.73.
Graeb score (mean 3.53) and modiﬁed Graeb (5.22)
scores were highly correlated. Using modiﬁed ABC/2,
ICH volume was underestimated in regular (by 2.2-
2.5 cm3, p<0.0001) and irregular-shaped haemorrhages
(by 4.8-4.9 cm3, p<0.0001). Fully automated
measurement of haemorrhage volume was possible in
only 5% of cases.
Conclusions Formal measurement of haemorrhage
characteristics and visual estimates are reproducible. The
standard ABC/2 method is superior to the modiﬁed
ABC/2 method for quantifying ICH volume.
Clinical trial registration ISRCTN9941422.
INTRODUCTION
Spontaneous intracerebral haemorrhage (ICH) is
usually a severe form of stroke with a high mortal-
ity rate (∼50%) by the end of the ﬁrst year.1 Poor
functional outcome is related independently to
increased age, systolic blood pressure, stroke sever-
ity and reduced level of consciousness.
Radiologically, haemorrhage size, haemorrhage
expansion, evidence of continuing bleeding (eg,
‘spot sign’ on CT angiography)2 3 and presence of
intraventricular haemorrhage (IVH) are all also
associated with poor outcome.4 5 The combination
of ICH volume and initial Glasgow Coma scale was
reported to be the strongest independent predictor
of 30-day outcome.1 Hence, reliable measurement
of haemorrhage size is an important component of
early clinical management and for stratiﬁcation in
clinical trials.
Although any effective intervention will ultim-
ately need to show an effect on functional outcome
(eg, using the modiﬁed Rankin Scale (mRS))6 in
phase III trials, earlier developments will need to
study the effect of treatment on a surrogate
measure. Where the intervention aims to limit
haemorrhage expansion, accurate, reproducible
and validated measurement of haemorrhage size
(thereby allowing measurement of the change in
volume) will be critical. Hence, phase II trials of
blood pressure lowering and haemostatic interven-
tions have utilised measurement of haemorrhage
expansion as a key primary outcome.7 8
There are multiple methods for measuring haem-
orrhage volume on a CT scan, ranging from quali-
tative visual estimation to computerised automatic
measurement. Visual approaches (ie, visual size cat-
egorisation based on the largest diameter) are quick
while computerised methods might provide a con-
tinuous volume measure but require access to good
quality electronic image ﬁles. A common approach
is the ABC/2 method,9 which has been modiﬁed
such that haemorrhage slices are excluded if the
area is <25% of the largest slice and counted as
half if it is 25–75% of the largest slice.10
Alternatively, semiautomatic or fully automatic
computerised methods may be used, usually based
on manually outlining or thresholding areas or
volumes within regions of interest (ROI). The rela-
tive advantages and disadvantages of these
approaches reﬂect the balance between measure-
ment time, type of data required, accuracy and
availability of computer workstations, and sample
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size, as studied in part.11–14 Assessment of additional properties
of haemorrhage, such as shape and density15 and extension into
the ventricles or subarachnoid space, may also be useful.16 17
In this study, we assessed and compared methods for measur-
ing haemorrhage size, shape and density and IVH size. The data
come from the ‘Efﬁcacy of Nitric Oxide in Stroke’ (ENOS)
trial,18 which assessed the management of blood pressure in
acute stroke and included patients with ICH.
METHODS
Patients
Data came from the prospective international multicentre ENOS
trial, a study of blood pressure management in patients with
acute ischaemic stroke or ICH, and high blood pressure.18 The
trial had regulatory and ethics approvals in each participating
country, and all patients gave written consent, or a relative pro-
vided proxy consent if the patient lacked capacity. The main
inclusion criteria were acute stroke with motor deﬁcit, systolic
blood pressure of 140–220 mm Hg, and treatment could start
within 48 h of onset. Patients were recruited from 173 sites in
23 countries across ﬁve continents. Following the entry of base-
line demographic and clinical data into a secure internet-fronted
database, patients were randomised to transdermal glyceryl tri-
nitrate (5 mg) versus none for 7 days; those taking antihyperten-
sive agents immediately prior to their stroke were also
randomised to continue versus stop these, again for 7 days.
Participants had a baseline CT or MRI brain scan as part of
clinical care, usually before randomisation. Where possible, a
second (research) CT or MRI scan was performed at day 7±1
(end-of-treatment). DICOM, JPEG, PNG or GIF ﬁles are sent
to the coordinating centre. Any scans sent on ﬁlm were digitised
using a VICOM digitiser (VIDAR Diagnostic PRO Advantage,
USA). The following study assesses only those patients with a
CT scan. For each patient, images were received with the thin-
nest slices provided by CT scan machines using standardised
protocols in the recruiting centres. However, during the course
of the trial, more volumetric images were made available
because of advances in imaging technology.
Scan adjudication
Complete CT scan series were made available for assessment by
a group of seven adjudicators comprising accredited neurora-
diologists or neurologists trained in CT brain imaging assess-
ment in stroke (http://www.neuroimage.co.uk/sirs, with
coordination by JMW).19 Images were viewed over the web,
blind to all clinical and treatment information except for patient
age, time since onset of stroke and side of brain symptoms.
Responses were entered directly into the trial database via a
web-based response form. Collected information included
whether the patient had an ICH and its location; an estimate of
its size (sorted into ordered categories based on the longest
diameter in any plane): <3, 3–4.9, 5–8, >8 cm; and the pres-
ence of other qualitative ﬁndings (mass effect,19 atrophy,19
white matter disease,20 old infarct or haemorrhage) using vali-
dated scoring methods.
Scan haemorrhage quantiﬁcation
Scans were visualised and analysed using OsiriX for Mac (V.3,
32 bit, http://www.osirix-viewer.com21 on a 26 inch Apple iMac.
Two trained observers (KK, SFM) measured baseline ICH volumes
of 193 patients using ABC/2, modiﬁed ABC/2, semiautomatic seg-
mentation (SAS) and automatic volume calculation (AVC, using
three-dimensional (3D) rendering of a stack of two-dimensional
slices). Both observers assessed scans blinded to each other’s
data, and repeated a proportion of the scans (47 and 34 scans
for KK and SFM, respectively) at a different time blinded to
their original measurements. Thus, intraobserver and interobser-
ver variation could be estimated. For the remaining 355
patients, one observer (KK) calculated ICH volumes using all
four methods.
The ABC/2 method requires measurement of the longest
diameter of the haemorrhage in the axial plane (‘A’), longest axis
at 90° to ‘A’ in the axial plane (‘B’), and the number of slices
(‘C’) showing the haemorrhage (noting that slice thickness may
vary through the scan). ‘C’ is the product of slice thickness and
number of slices showing any haemorrhage. Volume is calcu-
lated as A×B×C/2.9 In the modiﬁed ABC/2 method, the area of
haemorrhage seen on a slice has to be at least 25% of the haem-
orrhage area seen on the largest slice if the slice is to be consid-
ered in ‘C’; if the area is more than 75% of the largest area, the
slice counts as 1, and 0.5 if the measured value of the area is
between 25% and 75%.10
For SAS and AVC, it was possible to use thresholds so that the
haemorrhage ROI was measured within certain segmentation
parameters. Upper and lower attenuation values (typically 40–
80 HU) of haemorrhage were established manually by sampling
from the haemorrhage and normal brain. Where the threshold
did not exclude non-haemorrhage areas (as with the pineal
gland, calciﬁed choroid plexus, bone) in close proximity with
the haemorrhage, the haemorrhage boundary was manually
edited. The area of each slice that was included within these
parameters was measured, added together and multiplied by
scan thickness to obtain the SAS volume. AVC used an Osirix
‘3D growing region (entire series)’ method after selecting a
threshold part of the haemorrhage near to its centre. With all
methods, IVH blood was included in the ﬁnal ICH volume.
Additionally, four haemorrhage characteristics (area, perimeter,
mean attenuation and SD of attenuation) were recorded for the
haemorrhage from the slice with the largest area of haemorrhage.
Haemorrhage shape and density indices were then calculated as:
Shape index ½ref: 22] ¼ perimeter2=4Y area
Density index ½ref: 23] ¼ SD=meanðie; coefficient of variationÞ
The divergence in visual appearance of haemorrhage shape and
density were also assessed used an ordered categorical scale (1–5)
where for an extra lesion edge or degree of density variation an
additional point was given on the shape scale or density scale.15
Similarly, intraventricular blood volume was assessed visually
using the Graeb score and modiﬁed Graeb ordered categorical
scales.16 17 The Graeb score is calculated by scoring the amount
of blood in the lateral ventricles separately (score of 1=trace of
blood to a maximum of 4=ventricle full of blood and expanded)
and adding this to the scores for the third and fourth ventricles
separately (1=blood present and 2=ﬁlled with blood and
expanded) to derive a maximum score of 12. The modiﬁed
Graeb score allocates scores for separate ventricular compart-
ments (1≤25% ﬁlled with blood to 4≥75% ﬁlled with blood) to
reﬂect selective regional accumulation of blood and an extra one
point for expansion of each ventricle. The maximum score is 32.
Intraobserver and interobserver reliability was determined for
visual categorisation of shape and density. In addition, intraobserver
reliability was assessed for measured shape, density index, Graeb,
modiﬁed Graeb and IVH volume over different reading sessions,
separated by a minimum of 14 days. All adjudication and haemor-
rhage measurements were made blind to baseline and follow-up
clinical information, other imaging and treatment assignment.
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Statistical analysis
Data are shown as number (%), median (IQR) or mean (SD).
Measurement of intraobserver and interobserver variability was
assessed using the intraclass correlation coefﬁcient (ICC).24 A
probability value of <0.05 was considered statistically signiﬁ-
cant. Analyses were performed using SPSS (V.21) and checked
with Medistat running on an Apple Mac.
RESULTS
Altogether, 629 patients with ICH were enrolled into
ENOS.25 26 Of these, 548 patients had CT-conﬁrmed ICH and
a baseline scan available for measurement; 81 other patients
either had ICH diagnosed on MRI or had no CT scan available,
and these were excluded. Patient demographic and clinical
details are shown in table 1. The mean age of the 548 patients
in the present analysis was 67 (SD 12) years, 66% of patients
were male, mean baseline blood pressure was 171 (19)/92
(13) mm Hg, and the median time from onset of ictus to per-
forming neuroimaging was 4.5 (IQR 5.6) hours. When adjudi-
cated visually by experts, 63% of haematomas were located in
the middle cerebral artery territory (table 1); most haemor-
rhages caused a mass effect (86%) and many patients had leu-
koaraiosis (66%) and/or a previous stroke lesion (49%) present
on their scans. The most frequent visually assessed haemorrhage
length category was 3–5 cm (224, 41.3%), closely followed by
<3 cm (220, 40.6%) with much fewer larger haemorrhages.
The mean measured haemorrhage length was 3.4 cm (longest
diameter; table 1).
ICH volume
ICH volume was signiﬁcantly different between ABC/2, modi-
ﬁed ABC/2 and SAS: 12.8 (mean) (SD 16.3), 8.9 (9.2), 12.8
(13.1) cm3, respectively (p<0.0001) (table 2). The ICC was
‘excellent’ at 0.84–0.96 when comparing the observers’ measure-
ments for each of ABC/2, modiﬁed ABC/2 and SAS (table 2).
The observers found haemorrhage volume to be larger, by an
average of 2.7–4 cm3 with standard ABC/2, as compared to
modiﬁed ABC/2, and 1.4–4 cm3 smaller with SAS as compared
to modiﬁed ABC/2. As the mean ICH value increased, the differ-
ence between ICH volume measured by modiﬁed ABC/2 versus
the other two methods increased (ﬁgures 1 and 2), but no signiﬁ-
cant difference was observed between standard ABC/2 and SAS
(table 2; ﬁgure 3). The slope of the best-ﬁt regression line for the
increasing difference between modiﬁed ABC/2 versus ABC/2 was
−0.44, and −0.36 for modiﬁed ABC/2 versus SAS (both
p<0.0001) (ﬁgures 1 and 2).
There was good intraobserver agreement for measurements
assessed on 34–47 scans (5–10% of the total of 548). For ABC/2,
modiﬁed ABC/2 and SAS, the intraobserver ICC was ‘excellent’,
ranging between 0.97–0.98, and 0.95–0.99, respectively (table 3).
There was excellent interobserver agreement (ICC) based on
193 scans at 0.88 for ABC/2, 0.91 for modiﬁed ABC/2 and
0.93 for SAS (table 4). Both ABC/2 and modiﬁed ABC/2
showed excellent correlation with SAS (p<0.0001, see online
supplementary ﬁgures S1–S3). Only 23 of 548 scans were amen-
able to analysis using the fully AVC method as the software was
unable to handle the scan image with varying slice thickness;
this approach was therefore ignored in further analyses.
Across the ICH visual size categories, ICH volumes calculated
by modiﬁed ABC/2 were signiﬁcantly smaller compared to SAS
(ﬁgure 4). As the ICH size category increased, the difference
between modiﬁed ABC/2 and SAS also increased. By compari-
son, there was no signiﬁcant difference between ICH volumes
Table 1 Baseline demographic, clinical and neuroradiological
factors in 548 patients with primary intracerebral haemorrhage in
the ENOS trial
Variable Data
Demographics
Age (years) 67.9 (12.1)
Sex, male (%) 360 (65.7)
Country, UK (%)
Asia 117 (21.4)
Europe 67 (21.4)
Other (Africa, Australasia and North America) 42 (7.7)
UK 322 (58.8)
Clinical findings
Premorbid modified Rankin Scale=0 (%) 418 (76.3)
Previous stroke (%) 69 (12.6)
Prior antihypertensive medication use (%) 227 (41.4)
Prior history of high BP (%) 341 (62.2)
Diabetes mellitus (%) 67 (12.2)
Ischaemic heart disease (%) 56 (10.2)
Atrial fibrillation (%) 30 (6.5)
Total anterior circulation syndrome (%) 195 (35.6)
SSS (/58) 30.1 (12.3)
National Institutes of Health Stroke Scale (/42) 12.8 (5.3)
Systolic BP (mm Hg) 171.6 (19.3)
Diastolic BP (mm Hg) 92.2 (13.3)
Heart rate (bpm) 77.7 (14.5)
Time, stroke to neuroimaging (h) 4.5 [11.6]
Adjudicated CT scan findings
Location of haemorrhage (%)
MCA 346 (63.1)
ACA 22 (4.0)
PCA 5 (0.9)
MCA+ACA 2 (0.4)
Borderzone 14 (2.6)
Lacunar (ie, small subcortical) stroke 142 (25.9)
Brainstem and/or cerebellum 16 (2.9)
Leukoariosis 362 (66.1)
Lesion mass effect (minimal to extreme swelling) 470 (85.9)
Previous stroke lesion 270 (49.3)
IVH 141 (25.7)
Intracerebral haematoma size category (%)
<3 cm 220 (40.6)
3 to <5 cm 224 (41.3)
5 to 8 cm 87 (16.1)
>8 cm 11 (2.0)
Measured CT scan findings
Volume, ABC/2 (cm3) 12.77 (16.32)
Longest diameter (cm) 3.38 (1.4)
With IVH, n=141
Graeb score (/12)16 3.52 (2.4)
Modified Graeb score (/32)17 5.19 (4.7)
Without IVH, n=407
Shape (/5)15 3.00 (1.4)
Shape index22 1.22 (1.1)
Density (/5)15 2.54 (1.3)
Density index23 0.19 (0.1)
Data are number (%), median (semiquartile range), or mean (SD).
NIHSS calculated from SSS scores range from 0 (comatose with quadriplegia) to 58
(normal neurological status).
ACA, anterior cerebral artery territory; BP, blood pressure; ENOS, Efficacy of Nitric
Oxide in Stroke; IVH, intraventricular haemorrhage; MCA, middle cerebral artery
territory; NIHSS, the National Institutes of Health Stroke Scale; PCA, posterior cerebral
artery territory; SAS, semiautomatic segmentation; SSS, Scandinavian Stroke Scale.
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measured by standard ABC/2 and SAS when compared by ICH
visual size categorisation (ﬁgure 4).
There was good agreement between the adjudicators across
ICH visual size categories (n=47, ICC 0.82, p<0.001) (see
online supplementary table I) using the ordered categorical scale
(<3, 3–4.9, 5–8, >8 cm)19 and strong agreement between the
visual size category and the observer’s largest measured diameter
in the axial plane ‘A’ (ICC 0.71, p<0.001) (see online supple-
mentary table II).
ICH volume and shape
The most common shape was irregular (64%), followed by
regular ICH. Small ICHs (5.5–8.06 cm3) were more regularly
shaped than larger haemorrhages (p<0.0001) (table 5). Using
modiﬁed ABC/2, haemorrhage volume was signiﬁcantly lower
for regular-shaped haemorrhages when compared with ABC/2
(by 2.2 cm3) and SAS (by 2.4 cm3) (table 5 and ﬁgure 5); the
difference was greater with larger irregular-shaped haemor-
rhages (between standard ABC/2 and modiﬁed ABC/2 by
4.8 cm3 and SAS and modiﬁed ABC/2 by 4.9 cm3). When com-
pared by shape, ICH volume calculated by standard ABC/2 did
not differ from that measured by SAS (ﬁgure 5).
ICH shape and density in patients with no IVH
Intra-agreements and interagreements were both ‘good’ for
visual assessments of haemorrhage shape: intraobserver ICC
0.88 (see online supplementary table III), interobserver ICC
0.75 (n=47) (see online supplementary table IV); and density:
intraobserver ICC 0.86, interobserver ICC 0.73. Intra-observer
ICC was 0.53 for calculated shape index and 0.86 for density
index (see online supplementary table III).
IVH volume and severity
Intraobserver agreement for assessment of IVH volume on base-
line scans from 49 patients was excellent (ICC 0.98–0.99)
whether using the Graeb score, modiﬁed Graeb score or SAS
(see online supplementary table III). The Graeb and modiﬁed
Graeb scores were highly correlated with each other (rs=0.88,
p<0.01). Both were also highly correlated with measured IVH
volume using the SAS method: Graeb, (rs=0.73, p<0.01);
modiﬁed Graeb (rs=0.72, p<0.01).
Comparison of ICH volume by ABC/2, modiﬁed ABC/2 to SAS
We performed a non-systematic review to compare our study
with previously published work comparing ABC/2, modiﬁed
ABC/2 and SAS volume measures in ICH10–14 27–30 (see online
supplementary ﬁgures S4–S7).
Some studies used the standard ABC/2 formula while others
used variations of it;10 11 Gebel et al11 used the central haemor-
rhage slice to measure the largest diameter ‘A’ and found higher
volumes computed by ABC/2 when compared to SAS. With
regard to shape, three studies studied errors in warfarin-related
haemorrhage due to higher frequencies of irregular shape.12–14
Table 2 Comparison by two observers of different methods for
measuring haemorrhage volume (cm3) on CT scans: ABC/2 versus
modified ABC/2 versus SAS
Haematoma volume Difference p Value ICC
Observer 1
n=548
ABC/2
12.77 (16.32)
Modified ABC/2
8.90 (9.21)
3.96 <0.0001 0.84
ABC/2
12.77 (16.32)
SAS
12.76 (13.06)
−0.01 1.00
SAS
12.76 (13.06)
Modified ABC/2
8.90 (9.21)
3.97 <0.0001
Observer 2
n=193
ABC/2
12.05 (12.40)
Modified ABC/2
9.70 (10.05)
2.67 <0.0001 0.96
ABC/2
12.05 (12.40)
SAS
11.08 (11.38)
0.05 0.89
SAS
11.08 (11.38)
Modified ABC/2
9.70 (10.05)
1.38 <0.0001
Data are mean (SD), difference (Δ) in haemorrhage volume between ABC/2 and SAS
and ICC.
ICC, intraclass correlation coefficient; SAS, semiautomated segmentation.
Figure 1 The Bland–Altman plot for
assessment of variation in estimating
haematoma volume between modiﬁed
ABC/2 and standard ABC/2 (n=548),
r2=0.64, p<0.0001. The continuous
and dotted lines represent the
regression lines. The slope of the
best-ﬁt regression line gradient was
−0.44 (p<0.0001).
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Huttner et al12 showed that volumes of regular shaped haema-
tomas using ABC/2 were signiﬁcantly increased in regular and
irregular shaped haemorrhages. However, the large slice thick-
ness used during CT image acquisition in this study may have
produced signiﬁcant errors during calculation.12
This review comparing all three methods showed that the
ABC/2 formula tended to marginally overestimate the ICH
volume, but there was no absolute signiﬁcant difference com-
pared to SAS (see online supplementary ﬁgure S4); when
assessed by variability in haemorrhage shape, the results follow
the same sequence (see online supplementary ﬁgure S5). By
comparison, ICH volumes computed using modiﬁed ABC/2 are
signiﬁcantly smaller when compared with SAS; the difference is
greater as the haemorrhage sizes became larger and more irregu-
lar (see online supplementary ﬁgures S6 and S7).
DISCUSSION
To the best of our knowledge, this is the ﬁrst study that com-
pares several methods for assessing volume of spontaneous ICH
and IVH volume on CT scanning and tests the effect of haema-
toma shape and regularity on these measures. The major ﬁnd-
ings are as follows: (1) Agreement within and between observers
was excellent for measures of haemorrhage volume (ABC/2,
modiﬁed ABC/2, SAS) and other haemorrhage parameters
(visual categorisation by maximum length, description of shape,
density and IVH); (2) haemorrhage volumes measured by modi-
ﬁed ABC/2 were signiﬁcantly lower than those measured by
ABC/2 and SAS planimetry; the discrepancy increased as the
haematoma size became larger; (3) larger haemorrhages were
signiﬁcantly more irregular in shape; (4) agreement was good
between visual size categorisation and measured computerised
Figure 2 The Bland–Altman plot for
assessment of variation in estimating
haematoma volume between modiﬁed
ABC/2 and semiautomatic
segmentation (n=548), r2=0.45,
p<0.0001. The continuous and dotted
lines represent the regression lines. The
slope of the best-ﬁt regression line was
−0.36 (p<0.0001).
Figure 3 The Bland–Altman plot for
assessment of variation in estimating
haematoma volume (n=548) using
ABC/2 and semiautomatic
segmentation (n=548), r2=0.03,
p<0.0001. The continuous and dotted
lines represent the regression lines. The
slope of the best-ﬁt regression line was
0.02 (p<0.0001).
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measurement of maximum haemorrhage diameter; (5) attempts
to perform a fully automated volume measurement method
failed in more than 95% of patients, as the software was unable
to work with scans in which slice thicknesses varied.
The sources of error that effect variation between ABC/2 and
SAS merit consideration. First, the largest diameter of haemor-
rhage was measured in the axial plane but this may not be the
largest ICH diameter, which may also have contributed to dif-
ferences between ‘A’ and the visual size categorisation. Sucu
et al31 suggested using the maximum length and width not
necessarily on the same slice and found better correlation
between ABC/2 and SAS. However, this adaptation applies only
to chronic subdural haematomas which differ from spontaneous
haemorrhages by extending to the cranial vault and being cres-
centic.31 Second, when using ABC/2, the scan plane is measured
through AB/2, the formula for the area of a triangle. However, a
triangle is not necessarily the most appropriate description of a
haematoma. Last, standard ABC/2 approximates the haematoma
volume as an ellipsoid with all three axes extending in three per-
pendicular directions9; to compensate for the varying slice
thickness, ‘C’ is derived by multiplying the number of slices of
which the haematoma is seen by the slice thickness in centi-
metres. For the modiﬁed ABC/2, ‘C’ does not include slices if
the area of the haemorrhage is less than 25% of the largest
area,10 an approach that has no theoretical justiﬁcation. Hence,
this method does not estimate all three Cartesian coordinates of
the ellipsoid. Since the modiﬁed ABC/2 method underestimated
the ICH volume (by 2–4 cm3), and small differences in volume
equate to the variation in outcome,32 the modiﬁed ABC/2
method cannot be recommended. Further, modern CT scanners
provide thin slices and the ability to directly measure ‘C’,
thereby eliminating the need for approximating slice areas.33 34
Although computer-assisted methods are considered the gold
standard for volume measure,1 11 12 35 the SAS method was
time consuming and at times technically challenging. For
instance, it was difﬁcult to set segmentation parameters to iden-
tify a haemorrhage that was adjacent to the bone; and the
threshold may miss an area of haemorrhage. Additionally, the
threshold method will not account for oedema associated with
the ICH, which increases the mass effect; thus, the space-
occupying effect of the ICH may be much larger than its mea-
sured hyperattenuated area. As segmentation is semiautomatic,
it is feasible to adjust manually for errors if they are apparent,
although any adjustment may be subjective. All images require
visual checking and manual correction; failure to do this would
result in erroneous measurements. The problem is compounded
by more irregular spontaneous haemorrhages, for example, due
to amyloid, in anticoagulant-associated bleeds and in traumatic
haematomas, where typically lesions are irregular, of varied
attenuation and often next to the bone.
In this series of patients with spontaneous ICH, a high pro-
portion (64%) of irregular-shaped haemorrhages were found.
The effectiveness of the ABC/2 method has been validated in
regular, oval-shaped haemorrhages but researchers have doubted
its accuracy in complex irregular haemorrhages (eg, as seen with
warfarin or in large or amyloid-related haemorrhage) and those
with intraventricular extension.12 35 It has been suggested that
adjusting the denominator from 2 to 3 in ABC/2 in irregularly
shaped haematomas may produce more accurate measures, but
this concept is yet to be supported.12 14 Combining the present
and published ﬁndings,29 it may be postulated that as the haem-
orrhage became more irregular, the surface area and volume
changes more than the largest diameter. Hence, the area of the
largest haemorrhage slice may be more representative of the
total haemorrhage size than its diameter. As a result, the true
Table 3 Intraobserver comparison for two observers of haemorrhage size (n=47, 34 scans, respectively) on baseline CT scans from patients
with ICH
Difference (p) ICC Difference (p) ICC
Observer 1 2
Measurement 1 2 1 2
Modified ABC/2 (cm3) 8.67 (8.34) 9.10 (8.34) 0.43 (0.80) 0.97 16.88 (14.60) 16.90 (14.63) 0.016 (0.97) 0.95
ABC/2 (cm3) 10.42 (10.28) 10.98 (10.79) −0.55 0.97 20.97 (19.32) 20.15 (17.98) 0.82 (0.39) 0.96
SAS (cm3) 11.11 (10.38) 11.69 (10.99) 0.58 (0.80) 0.98 19.41 (15.32) 19.42 (15.51) −0.11 (0.87) 0.99
Diameter (A) (cm) 3.41 (1.28) 3.37 (1.31) 0.04 (0.89) 0.98 3.89 (1.48) 4.01 (1.45) −0.12 (0.43) 0.96
Data are mean (SD), difference in means, and ICC.
ICC, intraclass correlation coefficient; ICH, intracerebral haemorrhage; SAS, semiautomatic segmentation volume.
Table 4 Interobserver comparison for two (observer 1 and 2;
n=193 scans) of haemorrhage volume (cm3) on CT scans from
patients with intracerebral haemorrhage (ICH)
Observer
1 2 Difference (Δ) ICC
ABC/2 10.58 (10.20) 12.05 (12.40) −1.40 0.88
Modified ABC/2 8.42 (8.53) 9.70 (10.05) −1.3 0.91
SAS 12.02 (12.05) 11.08 (11.38) 0.95 0.93
Data are mean (SD), difference (Δ) in haemorrhage volumes and ICC.
ICC, intraclass correlation coefficient; SAS, semiautomatic segmentation.
Table 5 Comparison of volumes (cm3) using ABC/2, modified
ABC/2 and semiautomated segmentation (SAS) (n=548) by
haematoma shape
Haematoma
volume
Difference
(Δ) p value
Regular (1,2)
n=198
ABC/2
8.06 (10.43)
Modified ABC/2
5.56 (6.31)
2.51 <0.0001
ABC/2
8.06 (10.43)
SAS
7.77 (8.75)
0.29 0.20
SAS
7.77 (8.75)
Modified ABC/2
5.56 (6.31)
2.21 <0.0001
Irregular
(3,5)
n=350
ABC/2
15.48 (18.37)
Modified ABC/2
10.66 (10.07)
4.81 <0.0001
ABC/2
15.48 (18.37)
SAS
15.62 (14.22)
−0.14 0.82
SAS
15.62 (14.22)
Modified ABC/2
10.66 (10.07)
4.96 <0.0001
Data are mean (SD), difference (Δ) in volume and p value.
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volume of an irregular haemorrhage may be better estimated
using SAS. This ﬁnding is important since irregular shape hae-
morrhages are more likely to expand and affect morbidity and
mortality.15
Our study is novel in design as it compares two commonly used
methods ABC/2 and the modiﬁed formula (25%/75% distinction)
with computer-assisted SAS and pragmatic visual scoring.
Moreover, haemorrhage shape was incorporated in the analysis so
that the source of error within each individual measurement
method was assessed further. Our results show good compatibility
between ABC/2 and computer-assisted SAS, irrespective of haema-
toma shape and poor approximation using modiﬁed ABC/2.
There are several potential explanations for variation in inter-
observer performance. Thinner slices may produce more accur-
ate volume measurement,33 34 although the scans were identical
for each observer. Alternatively, each additional slice to measure
increases the potential for errors. Furthermore, observers may
have chosen slightly different window settings. Additionally,
although the observers were all trained in using OsiriX, accuracy
in measurement does depend on operator experience.33 36
When comparing haemorrhage size on the basis of its longest
measured diameter (‘A’ in ABC/2) with an adjudicated visual cat-
egorisation, there was ‘strong’ agreement, within the adjudica-
tors and between the observers and adjudicators, with ICC
0.72. Hence, it is unsurprising that the visual category versus
the largest measured axial diameter has a slightly lower agree-
ment than some of the other measured values. Note that the
visual categorisation assigns an ordinal value based on the
largest size in any plane, not just the axial plane, and thus is not
the same as a linear measure of largest axial diameter.
Our study also shows that qualitative descriptors of haemor-
rhage characteristics of haemorrhage shape, density, presence of
Figure 4 Box plots of intracerebral
haemorrhage (ICH) volumes (n=548)
by visually estimated size and
corresponding volume measured by
ABC/2, modiﬁed ABC/2 and
semiautomatic segmentation (SAS).
The difference between modiﬁed ABC/
2 versus standard ABC/2 and modiﬁed
ABC/2 versus SAS increases as the size
category increases and is present in all
four size categories (<3 (p<0.0001),
3–5 (p<0.001), 5–8 (p<0.0001) and
>8 (p<0.0001)). There was no
signiﬁcant difference between standard
ABC/2 and SAS in all four size
categories.
Figure 5 Box plots of intracerebral
haemorrhage (ICH) volumes (n=548)
by visually assessed shape and
corresponding volume assessed by
ABC/2, modiﬁed ABC/2 and
semiautomatic segmentation (SAS)
show: (1) larger ICHs are irregular in
shape (p<0.0001); (2) the mean
difference between modiﬁed ABC/2
versus standard ABC/2 and modiﬁed
ABC/2 versus SAS increased as the
haematoma shape became more
irregular (p<0.0001). No signiﬁcant
difference was observed between
standard ABC/2 and SAS.
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IVH using the Graeb and modiﬁed Graeb scores can be reliably
measured and are reproducible.
Of note, when measuring density heterogeneity, we used only
the coefﬁcient of variation (cv), whereas Barras used four add-
itional measures (although these were apparently inferior to
cv).23 Calculation of shape index using parameters obtained
from the windowed haemorrhage had a low ICC of 0.53. When
this result is held in context with similar computed volumes, it
could be interpreted that the observer chose different threshold
settings which explain the source of variability.
This study has several strengths including the use of multiple
assessors, multiple methods for assessing haemorrhage
characteristics, and a large data set. To minimise measurement
error, observers were trained to use the OsiriX software for
measuring brain CT scan parameters and in recognition of hae-
morrhages. Similarly, CT adjudicators were experienced neuror-
adiologists. Multiple observers were used to allow measurement
of intraobserver and interobserver variation. The data set
involved patients from ﬁve continents and so the ﬁndings have
excellent external validity.
Nevertheless, the study has three signiﬁcant limitations. First, the
data come from a randomised controlled trial in acute stroke. Trial
exclusion criteria can limit the type of patients (and therefore vari-
ation in haemorrhage) so that the data set studied here did not
include patients with normal/low blood pressure, GCS<8, or
without motor signs. As a result, patients with very large haema-
toma were under-represented. Second, the time from stroke onset
to neuroimaging was relatively long (median 4.2 h), reﬂecting that
the ENOS protocol allowed enrolment up to 48 h after stroke.
Hence, ICH on later scans may already have developed some
peri-ICH oedema. Finally, just over 25% of the patients had meas-
urable IVH, and therefore the results do not represent a population
where IVH is more frequent. The failure to get a fully automated
volume measure in 95% of scans may be less of a problem with
other software that can handle scans of variable slice thickness.
In conclusion, the modiﬁed ABC/2 formula signiﬁcantly under-
estimates haemorrhage volume when compared to standard ABC/
2 and computer assisted semiautomated segmentation (SAS) the
difference increased as haematoma volume became larger and
more irregular in shape. Most relevant for clinicians, our results
show that the standard ABC/2 method offers more accurate quan-
tiﬁcation of ICH volume by the bedside. Although SAS is consist-
ent and reliable, the method is slow, reliant on manual
correction, advanced software and likely to cause delay in clinical
decision-making often in emergency situations. Further research
is required to create a faster computerised volumetric model for
accurate and reliable measurement of haematomas in the clinical
setting. Visual assessment using an ordered categorical scale has
the strength of providing an ‘instant’ marker of haemorrhage size
in the acute situation and can be applied in the absence of meas-
urement tools and historical cut ﬁlm data, and where very large
study sizes or very moved images preclude computer based ABC/
2 or SAS measurements. This study importantly shows that haem-
orrhage characteristics can be reliably measured as accuracy is
pivotal to clinical trials in which ICH volume change may be a
surrogate end point.
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